JPRN-UMIN000032073已完成未知
Safety and efficacy of Glecaprevir / Pibrentasvir combination therapy for chronic hepatitis C - including hemodialysis patients - - Safety and efficacy of Glecaprevir / Pibrentasvir combination therapy
ippon Medical School Chiba Hokusoh Hospital0 个研究点目标入组 1,200 人开始时间: 2018年4月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 95years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of allergy to Glecaprevir / Pibrentasvir 2.Severe liver dysfunction 3.pregnant woman or lactating mother 4.Hepatocellular carcinoma, or other malignant tumor. 5.severe depression 6.Judged by investigator not to be appropriate for inclusion in this study 7.Receiving contraindicated drugs for Glecaprevir and Pibrentasvir combined therapy
研究者
相似试验
尚未招募
不适用
Efficacy and safety of Glecaprevir/Pibrentasvir plus Ribavirin in Patients who failed Direct-acting antivirals; DAAs with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000031615Tokai University10
已完成
不适用
Efficacy and safety of glecaprevir/pibrentasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic Hepatitis CJPRN-UMIN000029652Saitama Medical University200
已完成
不适用
Safety and efficacy of glecaprevir/pibrentasvir combination therapy for hepatitis C infected patients with chronic hepatitis or liver cirrhosisJPRN-UMIN000031090Hokkaido University Hospital300
已完成
不适用
Safety and efficacy of glecaprevir/pibrentasvir combination therapy for hemodialysis patients with genotype 2 hepatitis C infectioJPRN-UMIN000036099Hokkaido University Hospital40
已完成
不适用
Efficacy and safety of glecaprevir and pibrentasvir in chronic hepatitis C patients with hemodialysisChronic hepatitis C with hemodialysisJPRN-UMIN000029781kitasato University school of medicine50